JPMorgan raised target for Swiss Life stock to CHF 765.00
Published on 10/09/2026 at 12:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- JPMorgan raised its Swiss Life target from CHF 745.00 to CHF 765.00 on October 5, 2026.
- First-half 2026 net profit rose 8.00 percent to CHF 649 million, while fee result increased 11.00 percent to CHF 430 million.
- Swiss Life stock was trading at EUR 948.50 at Lang & Schwarz on October 9, 2026, minus 0.09 percent versus EUR 949.40.
- The company is conducting a CHF 250 million buyback through March 31, 2027, and next reports fiscal 2026 results on March 3, 2027.
JPMorgan raised its Swiss Life target from CHF 745.00 to CHF 765.00 on October 5, 2026, while keeping an Underweight rating, Markets Insider reported. Swiss Life stock was trading at EUR 948.50 at Lang & Schwarz on October 9, 2026 at 12:10 p.m. CEST.
Target remains below the SIX price
The new CHF 765.00 target is 13.54 percent below the SIX last price of CHF 884.80 on October 9, 2026. The valuation gap matters because JPMorgan's revised target still points below the market quotation, despite the increase from CHF 745.00.
Swiss Life's first-half 2026 results provide the operating counterweight. Net profit increased 8.00 percent to CHF 649 million, while the fee result rose 11.00 percent to CHF 430 million, according to Yahoo Finance on September 1, 2026. Profit from operations increased 8.00 percent in local currency to CHF 967 million.
What does the buyback mean?
Swiss Life began a CHF 250 million share buyback on October 1, 2026, with the program scheduled to run through March 31, 2027. The official Swiss Life document sets a maximum of 272,866 shares, equal to 0.98 percent of the share capital, and says the repurchased shares may be proposed for cancellation at future annual meetings, Swiss Life states.
Three milestones frame the story
On July 1, 2026, Swiss Life completed the TELIS Group acquisition, which adds 1,800 advisors to its operating unit, according to Yahoo Finance. On September 1, 2026, the company reported first-half net profit of CHF 649 million and announced the CHF 250 million buyback through the same call. On October 5, 2026, Markets Insider reported JPMorgan's target increase to CHF 765.00.
Next dates are already defined
Swiss Life is scheduled to report fiscal 2026 earnings on March 3, 2027, according to Barrons. The buyback's latest possible end date is March 31, 2027, under the official Swiss Life program terms.
Swiss Life stock at Lang & Schwarz
At Lang & Schwarz, Swiss Life stock was trading at EUR 948.50 on October 9, 2026 at 12:10 p.m. CEST, minus 0.09 percent versus the prior close of EUR 949.40 on October 8, 2026. The SIX quotation was CHF 884.80 at 11:49 a.m. CEST on October 9, 2026, giving investors a separate view in the primary trading currency.
The further course of trading is shown by the continuously updated real-time quote of Swiss Life Holding stock.
Swiss Life Holding stock facts
- Company: Swiss Life Holding AG
- ISIN: CH0014852781
- Ticker: SLHN
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz (as of October 9, 2026, 12:10 p.m. CEST): EUR 948.50
- Change versus prior close: minus 0.09 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 949.40
- Market capitalization: CHF 24.7 billion (as of October 9, 2026)
- Sector / Industry: Financial Services / Insurance - Diversified
- Index membership: SMI
- Next earnings date: March 3, 2027
Market context: Market report SMI.
